ARTICLE | Top Story
Xenova halts colorectal study
June 1, 2000 7:00 AM UTC
Xenova (LSE:XEN; XNVA) said results of a Phase II trial with XR5000 to treat colorectal cancer showed two patients with stable disease and 13 with disease progression but no complete or partial respon...